Davidson Kempner Capital Management’s CONMED CNMD Stock Holding History

Davidson Kempner Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,293	Closed	-$954K	–	563
2021 Q3	$954K	Sell	7,293 -266,060	-97%	-$34.8M	0.01%	318
2021 Q2	$37.6M	Buy	273,353 +86,631	+46%	+$11.9M	0.29%	60
2021 Q1	$24.4M	Sell	186,722 -141,076	-43%	-$17M	0.24%	80
2020 Q4	$36.7M	Buy	327,798 +35,841	+12%	+$3.39M	0.43%	51
2020 Q3	$23M	Buy	291,957 +109,200	+60%	+$8.91M	0.33%	66
2020 Q2	$13.2M	Hold	182,757	–	–	0.32%	92
2020 Q1	$10.5M	Buy	182,757 +149,574	+451%	+$13.8M	0.28%	77
2019 Q4	$3.71M	Buy	33,183 +25,700	+343%	+$2.74M	0.08%	120
2019 Q3	$719K	Buy	+7,483	New	+$702K	0.01%	138

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Davidson Kempner Capital Management's CNMD Position: Q4 2021 in Review

Davidson Kempner Capital Management sold out of CONMED (CNMD) in Q4 2021, closing a stake of 7,293 shares — an estimated $954K sold.

Davidson Kempner Capital Management first reported a position in CNMD in Q3 2019 and held it in 9 quarters. The position peaked at $37.6M in Q2 2021. 264 funds tracked by Wall St. Rank hold CNMD as of Q4 2021.

Davidson Kempner Capital Management reported no remaining CONMED position as of Q4 2021 after selling out during the quarter.
Davidson Kempner Capital Management sold 7,293 CONMED shares in Q4 2021, an estimated $954K.
Davidson Kempner Capital Management first reported a position in CONMED in Q3 2019 and held it in 9 quarters.
Davidson Kempner Capital Management's CONMED position peaked at $37.6M in Q2 2021.
264 funds tracked by Wall St. Rank held CONMED as of Q4 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.